What this study is
Gastrointestinal (GI) infection with Campylobacter causes inflammation in the bowel and can change bacteria in the gut. Certain individuals with Campylobacter infection are also known to develop chronic bowel problems such as Irritable Bowel Syndrome (IBS). The researchers are doing this study to understand if changes in gut bacteria and gut mucosal lining during an acute infection can help identify individuals who might be at risk for developing problems in the future.
Study details
- Sponsor
- Mayo Clinic
- Conditions
- Irritable Bowel Syndrome
- Enrolling
- 150 people
- Starts
- 2014-10-31
- Est. completion
- 2026-06
- Record
- View on ClinicalTrials.gov ↗
Who can join
Age 18 Years – 80 YearsSex ALLHealthy volunteers Not acceptedYou may qualify if
- No abdominal surgery (except appendectomy and cholecystectomy)
- Stool culture or Polymerase chain reaction (PCR) positive enteritis with Campylobacter
You can't join if
- History of IBS, Irritable Bowel Disease (IBD) (Crohn's disease or ulcerative colitis), microscopic colitis or celiac disease.
- History of gastroenteritis in six months prior to Campylobacter enteritis
- Pregnancy
Sign in and we'll check these against your records.Full criteria on ClinicalTrials.gov ↗
Loading treatment details…
Study locations (1)
1 openMayo Clinic
Rochester, Minnesota, United States
- Margaret K Breen-Lyles, BS · Contact507-255-3520Breen-Lyles.Margaret@mayo.edu
Recruiting
Study team
Sponsor
Mayo Clinic
Study ID 14-006180
Principal investigator
Madhusudan Grover, MBBS
Mayo Clinic
Frequently asked questions
The sponsor hasn't published answers to common questions for this trial.